Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial
异基因造血干细胞移植后使用来那度胺维持治疗似乎会诱发高危骨髓增生异常综合征或急性髓系白血病伴del(5q)患者的急性移植物抗宿主病:LENAMAINT试验结果
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2012.067629
Sockel, Katja; Bornhaeuser, Martin; Mischak-Weissinger, Eva; Trenschel, Rudolf; Wermke, Martin; Unzicker, Christian; Kobbe, Guido; Finke, Jürgen; Germing, Ulrich; Mohr, Brigitte; Greiner, Jochen; Beelen, Dietrich; Thiede, Christian; Ehninger, Gerhard; Platzbecker, Uwe